
Syneos Health SYNH
Quarterly report 2023-Q2
added 05-16-2026
Syneos Health Shares 2011-2026 | SYNH
Annual Shares Syneos Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 103 M | 104 M | 104 M | 104 M | 103 M | 74.9 M | 54 M | 57.9 M | 53.3 M | 52 M | 52.2 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 104 M | 52 M | 78.4 M |
Quarterly Shares Syneos Health
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104 M | 103 M | - | 103 M | 103 M | 104 M | 104 M | 104 M | 104 M | 104 M | 104 M | 104 M | 104 M | 104 M | 104 M | 104 M | 104 M | 103 M | 103 M | 103 M | 103 M | 104 M | 104 M | 87.2 M | 54.1 M | 54 M | 53.8 M | 54.2 M | 54.3 M | 54 M | 53.9 M | 56.3 M | 58.2 M | 61.2 M | 61.2 M | 51.9 M | 51.9 M | 51.9 M | 104 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 104 M | 51.9 M | 85.3 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
304 M | $ 113.38 | -0.35 % | $ 34.5 B | ||
|
Celcuity
CELC
|
46.8 M | $ 137.79 | -1.82 % | $ 6.44 B | ||
|
Co-Diagnostics
CODX
|
1.33 M | $ 3.72 | 55.64 % | $ 4.95 M | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
29 M | $ 20.2 | 0.85 % | $ 586 M | ||
|
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 16.78 | 2.25 % | $ 507 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
125 M | $ 115.3 | 0.28 % | $ 14.5 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
53.3 M | $ 21.46 | 1.47 % | $ 1.14 B | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
82.5 M | $ 115.22 | 0.11 % | $ 9.5 B | ||
|
Interpace Biosciences
IDXG
|
4.42 M | $ 1.8 | - | $ 7.96 M | ||
|
Illumina
ILMN
|
159 M | $ 142.67 | 0.52 % | $ 22.7 B | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
67.5 M | $ 94.86 | -1.29 % | $ 6.4 B | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
49.6 M | $ 157.74 | 1.06 % | $ 7.82 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
28.8 M | $ 419.08 | -0.66 % | $ 12.1 B | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Mettler-Toledo International
MTD
|
20.6 M | $ 1 077.55 | -0.47 % | $ 22.2 B | ||
|
NeoGenomics
NEO
|
128 M | $ 8.83 | -0.79 % | $ 1.13 B | ||
|
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
22.4 M | $ 19.3 | 0.21 % | $ 432 M | ||
|
Natera
NTRA
|
98.4 M | $ 204.21 | -0.35 % | $ 20.1 B | ||
|
Myriad Genetics
MYGN
|
92.6 M | $ 3.75 | -1.71 % | $ 347 M | ||
|
Personalis
PSNL
|
89.2 M | $ 8.3 | 4.4 % | $ 741 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
948 M | $ 26.82 | 0.3 % | $ 25.4 B | ||
|
Senseonics Holdings
SENS
|
41.7 M | $ 5.78 | 1.14 % | $ 241 M | ||
|
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.32 | -1.28 % | $ 5.33 M | ||
|
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 253.88 | -1.34 % | $ 21.1 B | ||
|
Thermo Fisher Scientific
TMO
|
377 M | $ 447.14 | -0.99 % | $ 169 B | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
Trinity Biotech plc
TRIB
|
359 M | $ 0.61 | 1.67 % | $ 219 M | ||
|
Twist Bioscience Corporation
TWST
|
59.8 M | $ 53.12 | -1.01 % | $ 3.18 B | ||
|
Neogen Corporation
NEOG
|
217 M | $ 8.52 | -3.51 % | $ 1.85 B | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 192.03 | -0.89 % | $ 21.3 B | ||
|
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M |